BBH icon

VanEck Biotech ETF

111 hedge funds and large institutions have $152M invested in VanEck Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less ownership

Funds ownership:

16% less capital invested

Capital invested by funds: $180M → $152M (-$28.5M)

39% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 31

Holders
111
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$9.68M
2 -$9.21M
3 -$5.76M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.73M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$66.2K
77
$66.2K
78
$64.6K
79
$62K
80
$60K
81
$51K
82
$46.7K
83
$46.1K
84
$38.9K
85
$38.9K
86
$38.9K
87
$37.6K
88
$24.9K
89
$23.4K
90
$20.2K
91
$18.7K
92
$17K
93
$16.9K
94
$15.6K
95
$15.6K
96
$13.7K
97
$12.5K
98
$11.6K
99
$11.6K
100
$10.9K